FindTrial
Sign In

Gemcitabine (1000 mg/m2)

DRUG6 trials

Sponsors

SciClone Pharmaceuticals, Fudan University, National Cancer Institute, Egypt, Hospital Universitario Dr. Jose E. Gonzalez, Peking University First Hospital

Conditions

Advanced Pancreatic CancerDiffuse Pleural Mesothelioma (DPM)Pancreatic CancerRelapsed/Refractory Diffuse Large B Cell LymphomaUntreatedUpper Tract Urothelial Carcinoma

Phase 2

Phase II Study to Evaluate Efficacy and Safety of RP101 in Combination With Gemcitabine
TerminatedNCT00550004
SciClone PharmaceuticalsPancreatic Cancer
Start: 2007-09-30End: 2009-10-31Target: 153Updated: 2011-06-08
Gemcitabine as Maintenance Treatment for Diffuse Pleural Mesothelioma
CompletedNCT07411144
National Cancer Institute, EgyptDiffuse Pleural Mesothelioma (DPM)
Start: 2020-03-15End: 2023-03-15Updated: 2026-02-13
Low Dose Epcoritamab Plus GemOx in R/R DLBCL
RecruitingNCT07451652
Hospital Universitario Dr. Jose E. GonzalezRelapsed/Refractory Diffuse Large B Cell Lymphoma
Start: 2026-03-17End: 2027-09-01Target: 10Updated: 2026-04-01
Disitamab Vedotin Plus Radiotherapy for Adjuvant Treatment of HER2-Expressing Cisplatin-Ineligible Upper Tract Urothelial Carcinoma
Not yet recruitingNCT07498907
Peking University First HospitalUpper Tract Urothelial Carcinoma
Start: 2026-05-01End: 2034-03-01Target: 192Updated: 2026-03-27
A Clinical Study Evaluating a New Treatment Strategy for Patients With Advanced Pancreatic Cancer Who Have Not Received Prior Treatment for Advanced Disease.
Not yet recruitingNCT07578337
Nelum CorpAdvanced Pancreatic Cancer, Untreated
Start: 2026-07-15End: 2029-02-28Target: 40Updated: 2026-05-13

Phase 3

Active Anti-diabetic Treatment Plus Chemotherapy for Pancreatic Cancer Related Diabetes
Not yet recruitingNCT07272109
Fudan UniversityPancreatic Cancer
Start: 2026-01-01End: 2028-12-30Target: 210Updated: 2025-12-15

Related Papers

Gemcitabine as maintenance treatment of diffuse pleural mesothelioma: randomized phase II study
BMC Cancer2026-03-26
RP101 (brivudine) binds to heat shock protein HSP27 (HSPB1) and enhances survival in animals and pancreatic cancer patients.
2011-07-2271 citations